TR200100897T2 - Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri. - Google Patents
Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.Info
- Publication number
- TR200100897T2 TR200100897T2 TR2001/00897T TR200100897T TR200100897T2 TR 200100897 T2 TR200100897 T2 TR 200100897T2 TR 2001/00897 T TR2001/00897 T TR 2001/00897T TR 200100897 T TR200100897 T TR 200100897T TR 200100897 T2 TR200100897 T2 TR 200100897T2
- Authority
- TR
- Turkey
- Prior art keywords
- bile acids
- treatment
- lipid metabolism
- metabolism disorders
- propanolamine derivatives
- Prior art date
Links
- 150000003152 propanolamines Chemical class 0.000 title abstract 3
- 239000003613 bile acid Substances 0.000 title abstract 2
- 208000017170 Lipid metabolism disease Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19845403A DE19845403B4 (de) | 1998-10-02 | 1998-10-02 | Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100897T2 true TR200100897T2 (tr) | 2001-10-22 |
Family
ID=7883185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00897T TR200100897T2 (tr) | 1998-10-02 | 1999-09-18 | Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6180618B1 (https=) |
| EP (1) | EP1117676B1 (https=) |
| JP (1) | JP4598953B2 (https=) |
| KR (1) | KR20010075511A (https=) |
| CN (1) | CN1227259C (https=) |
| AR (1) | AR035003A1 (https=) |
| AT (1) | ATE273991T1 (https=) |
| AU (1) | AU757366B2 (https=) |
| BR (1) | BR9915019A (https=) |
| CA (1) | CA2346085A1 (https=) |
| DE (2) | DE19845403B4 (https=) |
| DK (1) | DK1117676T3 (https=) |
| ES (1) | ES2226440T3 (https=) |
| HK (1) | HK1040717A1 (https=) |
| HU (1) | HUP0103570A3 (https=) |
| ID (1) | ID29353A (https=) |
| PL (1) | PL347106A1 (https=) |
| PT (1) | PT1117676E (https=) |
| RU (1) | RU2234512C2 (https=) |
| TR (1) | TR200100897T2 (https=) |
| WO (1) | WO2000020437A1 (https=) |
| ZA (1) | ZA200102586B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| US7161008B2 (en) * | 2002-05-03 | 2007-01-09 | Sanofi - Aventis Deutschland GmbH | Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them |
| GB0213669D0 (en) * | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| GB0817969D0 (en) * | 2008-10-01 | 2008-11-05 | Axcess Ltd | Pharmaceutical composition |
| ES2552657T3 (es) | 2010-05-26 | 2015-12-01 | Satiogen Pharmaceuticals, Inc. | Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias |
| US20130108573A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| AU2012328526B2 (en) | 2011-10-28 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| AU2014229050A1 (en) | 2013-03-15 | 2015-10-22 | Lumena Pharmaceuticals Llc | Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease |
| CA2907230A1 (en) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease |
| EP3923943B1 (en) | 2019-02-12 | 2024-07-31 | Mirum Pharmaceuticals, Inc. | Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI892341L (fi) | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
| GB2250634A (en) * | 1990-12-04 | 1992-06-10 | Marconi Gec Ltd | Point contact diodes |
| US5250524A (en) | 1990-12-06 | 1993-10-05 | Hoechst Aktiengesellschaft | Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| JP2616845B2 (ja) * | 1991-02-21 | 1997-06-04 | 清水化学株式会社 | システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤 |
| GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
| ATE147384T1 (de) * | 1992-02-22 | 1997-01-15 | Hoechst Ag | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| TW289021B (https=) * | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
| EP0624593A3 (de) * | 1993-05-08 | 1995-06-07 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel. |
| EP0869121B1 (de) * | 1997-04-04 | 2004-06-09 | Aventis Pharma Deutschland GmbH | Hypolipidämische Propanolaminderivate |
-
1998
- 1998-10-02 DE DE19845403A patent/DE19845403B4/de not_active Expired - Fee Related
-
1999
- 1999-09-18 DK DK99947385T patent/DK1117676T3/da active
- 1999-09-18 JP JP2000574548A patent/JP4598953B2/ja not_active Expired - Fee Related
- 1999-09-18 DE DE59910300T patent/DE59910300D1/de not_active Expired - Lifetime
- 1999-09-18 HK HK02102338.5A patent/HK1040717A1/zh unknown
- 1999-09-18 BR BR9915019-0A patent/BR9915019A/pt not_active IP Right Cessation
- 1999-09-18 ES ES99947385T patent/ES2226440T3/es not_active Expired - Lifetime
- 1999-09-18 AU AU60855/99A patent/AU757366B2/en not_active Ceased
- 1999-09-18 HU HU0103570A patent/HUP0103570A3/hu unknown
- 1999-09-18 ID IDW20010737A patent/ID29353A/id unknown
- 1999-09-18 AT AT99947385T patent/ATE273991T1/de not_active IP Right Cessation
- 1999-09-18 PL PL99347106A patent/PL347106A1/xx unknown
- 1999-09-18 PT PT99947385T patent/PT1117676E/pt unknown
- 1999-09-18 EP EP99947385A patent/EP1117676B1/de not_active Expired - Lifetime
- 1999-09-18 CN CNB998116343A patent/CN1227259C/zh not_active Expired - Fee Related
- 1999-09-18 KR KR1020017004131A patent/KR20010075511A/ko not_active Ceased
- 1999-09-18 WO PCT/EP1999/006930 patent/WO2000020437A1/de not_active Ceased
- 1999-09-18 RU RU2001111816/04A patent/RU2234512C2/ru not_active IP Right Cessation
- 1999-09-18 TR TR2001/00897T patent/TR200100897T2/xx unknown
- 1999-09-18 CA CA002346085A patent/CA2346085A1/en not_active Abandoned
- 1999-09-29 US US09/408,169 patent/US6180618B1/en not_active Expired - Lifetime
- 1999-09-30 AR ARP990104961A patent/AR035003A1/es unknown
-
2001
- 2001-03-29 ZA ZA200102586A patent/ZA200102586B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1040717A1 (zh) | 2002-06-21 |
| WO2000020437A1 (de) | 2000-04-13 |
| KR20010075511A (ko) | 2001-08-09 |
| RU2234512C2 (ru) | 2004-08-20 |
| BR9915019A (pt) | 2001-08-14 |
| CN1321166A (zh) | 2001-11-07 |
| PT1117676E (pt) | 2004-11-30 |
| DE19845403A1 (de) | 2000-04-13 |
| CN1227259C (zh) | 2005-11-16 |
| DK1117676T3 (da) | 2004-12-20 |
| DE19845403B4 (de) | 2005-02-10 |
| ATE273991T1 (de) | 2004-09-15 |
| ES2226440T3 (es) | 2005-03-16 |
| PL347106A1 (en) | 2002-03-25 |
| JP4598953B2 (ja) | 2010-12-15 |
| AR035003A1 (es) | 2004-04-14 |
| HUP0103570A3 (en) | 2003-01-28 |
| US6180618B1 (en) | 2001-01-30 |
| JP2002526550A (ja) | 2002-08-20 |
| ID29353A (id) | 2001-08-23 |
| DE59910300D1 (de) | 2004-09-23 |
| EP1117676B1 (de) | 2004-08-18 |
| CA2346085A1 (en) | 2000-04-13 |
| EP1117676A1 (de) | 2001-07-25 |
| AU757366B2 (en) | 2003-02-20 |
| HUP0103570A2 (hu) | 2002-02-28 |
| ZA200102586B (en) | 2001-10-03 |
| AU6085599A (en) | 2000-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
| EA200001125A1 (ru) | Гелеобразные фармацевтические композиции | |
| ATE267798T1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
| BG103518A (en) | 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives | |
| ATE337019T1 (de) | Geladene lipide und deren verwendung | |
| EE9700146A (et) | Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine | |
| ATE257386T1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
| UY27438A1 (es) | Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica. | |
| DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
| PT902789E (pt) | Derivados de androsteno | |
| KR870700599A (ko) | 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도 | |
| TR200100897T2 (tr) | Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri. | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| ATE218868T1 (de) | Hustenhemmende, theobromine enthaltende zusammensetzungen | |
| HUP0400801A2 (hu) | Epesavak vagy epesavas só-zsírsav konjugátumokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| TR200100896T2 (tr) | İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları | |
| DE50207740D1 (de) | Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs) | |
| EE9700102A (et) | Selegiliini sisaldav liposoomne kompositsioon | |
| ATE40793T1 (de) | Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen. | |
| DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
| JPH083069A (ja) | 経皮吸収促進剤及び皮膚外用剤 | |
| FR2768145B1 (fr) | Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant |